Nuritas is one of those high potential start-ups that the government and state agencies like to talk about. Founded and headquartered in Ireland, it operates at the cutting edge of bio technology and has a blue chip roster of shareholders and backers. Led by its founder, the mathematician and bioinformatics specialist Dr Nora Khaldi, it uses big data techniques to discover peptides – molecules in food and food by-products – that can be used by the life sciences sector in supplements and new drugs. Potentially, it is a gamechanger. And that potential was enough to convince the European Investment Bank…

Want to continue reading?

Join today and get full access to The Currency and The Wall Street Journal – TWO premium memberships for the price of one.

Subscribe

Cancel at any time.

Are you already a member? .